Mucosal ACP subunit vaccine formulated with a small molecule STING agonist drives protective TH1/TH17 responses and serum bactericidal antibodies against Neisseria gonorrhoeae
Abhishek Chanda, Ines A Cadena, Junaid Nazir, Laura Springgay, Ian P Rose, Jinu Abraham, Chenwei Lin, Mansab Ali Saleemi, Andrew N Macintyre, Victor R. DeFilippis, Aleksandra E. Sikora
This study evaluates a mucosal vaccine combining ACP and diABZI, showing enhanced TH1/TH17 responses and serum bactericidal activity against Neisseria gonorrhoeae.
bioRxiv · Nov 3, 2026 · PreprintMicrobiology